WHO collaborating centres are defined as institutions such as research institutes, parts of universities or academies, which are designated by the World Health Organization (WHO) to carry out activities in support of the Organization's programmes (see https://www.who.int/collaboratingcentres/en/).
‘As early as 1949, the Second World Health Assembly laid down the policy (which has been constantly followed since) that the Organization should not consider "the establishment, under its own auspices, of international research institutions" and the "research in the field of health is best advanced by assisting, coordinating and making use of the activities of existing institutions".’
The importance of the Department’s activities in the areas of pharmaceutical pricing and reimbursement has been acknowledged by the WHO that nominated in 2010, and re-designated in 2014 and 2018, the Pharmacoeconomics Department as WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies.
WHO Collaborating Centre and Pharmacoeconomics Department
Most of the activities of the Pharmacoeconomics Department also fall under the scope of work agreed between the WHO Collaborating Centre and WHO. According to the current Terms of Reference, the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies is tasked:
- Upon WHO’s request and leadership, to provide scientific advice and technical assistance to WHO and its Member States / regions on performing and interpreting price surveys and comparisons, on understanding, collecting, reviewing and analysing pharmaceutical pricing and reimbursement information and on the development of national reporting systems.
- Under WHO's leadership, to further develop and refine the methodological framework to measure, compare and analyze pharmaceutical policies particularly related to pricing, reimbursement and rational use of medicines.
- Upon WHO’s request, to support the organization of technical meetings in the field of pharmaceutical pricing and reimbursement allowing for an exchange of information and experiences, to disseminate information on pharmaceutical policies in line with WHO norms, standards and policies, to offer trainings, seminars and further capacity-building activities at request of WHO to work on the development and promotion of a common understanding and language on pharmaceutical issues.